Showing results (111-120 of 159) with videos related to
Sort By:
Pageof 16
Biorxiv : the Preprint Server for Biology|January 20, 2025
Chemoproteomic Profiling of <i>C. albicans</i> for Characterization of Anti-fungal Kinase InhibitorsDavid J Shirley, Meganathan Nandakumar, Aurora Cabrera, et al.Journal of Medicinal Chemistry|May 10, 2013
Optimized chemical probes for REV-ERBαRyan P Trump, Stefano Bresciani, Anthony W J Cooper, et al.Journal of Medicinal Chemistry|March 24, 2015
Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2BPeiling Chen, Apirat Chaikuad, Paul Bamborough, et al.Nature|February 15, 2002
Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalphaH Eric Xu, Thomas B Stanley, Valerie G Montana, et al.Journal of Medicinal Chemistry|March 30, 2010
Discovery of tertiary sulfonamides as potent liver X receptor antagonistsWilliam J Zuercher, Richard G Buckholz, Nino Campobasso, et al.Biochemistry|May 23, 2002
Functional consequences of cysteine modification in the ligand binding sites of peroxisome proliferator activated receptors by GW9662Lisa M Leesnitzer, Derek J Parks, Randy K Bledsoe, et al.Bioorganic & Medicinal Chemistry Letters|July 30, 2011
Discovery of GSK1997132B a novel centrally penetrant benzimidazole PPARγ partial agonistMairi Sime, Amanda C Allan, Paul Chapman, et al.Molecules (Basel, Switzerland)|September 14, 2024
Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2Han Wee Ong, Xuan Yang, Jeffery L Smith, et al.RSC Medicinal Chemistry|November 26, 2025
Identification of spirodioxolane nsP2 helicase inhibitors with antialphaviral activityHans J Oh, John D Sears, Bose Muthu Ramalingam, et al.Blood|September 15, 2025
Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myelomaZhibo Yan, Zhannan Han, Yihui Wang, et al.Pageof 16